Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with ESLA: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
ESLA
Estrella Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
ESLA
Estrella Immunopharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
AMGN
4 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.7%
▲
+3.73%
×1.00
Q2 FY26
±4.1%
▲
+4.57%
×1.12
Q1 FY26
±3.9%
▼
−4.75%
×1.23
Feb 4 '26
±3.7%
▲
+8.15%
×2.22
ESLA
No earnings history for ESLA.
= implied
AMGN realized, solid
ESLA realized, hatched
One scale, both sides: full bar = 9%
× = |realized| ÷ implied
Source: market data
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
ESLA
Estrella Immunopharma, Inc.
Change
0.39
▼
−4.05%
· post 0.39
Closed
Nov 6 '26
Mkt cap
$16.3M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
AMGN
Amgen Inc
vs
ESLA
Estrella Immunopharma, Inc.
460.55
▲
+0.06%
post 460.42
Price
0.39
▼
−4.05%
post 0.39
$249.0B
Mkt cap
$16.3M
Q3 FY26
$10.4B
Revenue
—
FY25
$36.8B
Revenue
—
Change
Change
AMGN
460.55
▲
+0.06%
vs
ESLA
0.39
▼
−4.05%
Closed
Nov 6 '26